Mucifat

Mucifat

sucralfate

Manufacturer:

Meprofarm

Marketer:

Meprofarm
Full Prescribing Info
Contents
Sucralfate.
Description
Sucralfate is a chemical complex formed by sucrose octasulfate and polyalumunium hydroxide.
Action
Pharmacology: Sucralfate activity as an anti ulcer is a result of the complexes that made by sucralfate and the proteins that form a protecting layer to the ulcer and also protects against gastric acid, pepsin and bile salts.
Sucralfate heals ulcers in 3 ways: 1) Establish a chemical compound that is bound to the central ulcer and form a protective layer. 2) Inhibiting the action of acid, pepsin and bile salts. 3) Inhibit gastric acid diffusion through the film layer of sucralfate-albumin.
Sucralfate may stay for long period of time in the gastrointestinal tract after it has been administered, resulting in long-term drug effects. Sucralfate is slightly absorbed via the gastrointestinal tract that makes this drug with minimal systemic side effects.
Indications/Uses
Short-term treatment of duodenal ulcer (No longer than 8 weeks).
Dosage/Direction for Use
Adult: 2 teaspoon (10 ml) four times daily, on empty stomach (an hour before meal or before bedtime). Treatment should remain, unless the results of endoscopic or x-rays examination have shown recovery.
Contraindications
Hypersensitivity to any component of this medication.
Special Precautions
Sucralfate should be administered with caution to patients with renal failure or patients on dialysis. Sucralfate usage during pregnancy should be done when absolutely necessary. Sucralfate should be administered with caution in women on lactation. Antacids may be given half an hour before or after sucralfate administration if needed. Safety and effectiveness in children have not been established yet.
Use In Pregnancy & Lactation
Sucralfate usage during pregnancy should be done when absolutely necessary. Sucralfate should be administered with caution in women on lactation.
Adverse Reactions
The occurrence of side effects are very rare, generally reported reactions are constipation and dry mouth. Other complaints are diarrhea, nausea, vomiting, gastrointestinal discomfort, flatulence, pruritus, rash, drowsiness, dizziness, back pain and headache.
Drug Interactions
Sucralfate may reduce the absorption and bioavailability of these drugs: cimetidine, ciprofloxacin, digoxin, ketoconazole, norfloxacin, phenytoin, ranitidine, tetracycline and theophylline, so these drugs should be administered two hours prior to administration of sucralfate.
Storage
Store below 30°C.
Keep out of reach of children.
ATC Classification
A02BX02 - sucralfate ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Oral susp 500 mg/5 mL x 100 mL x 1's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in